While Alzheimer’s disease (AD) type amyloid-beta peptide (Aβ) deposition in senile plaques may play a role in age-related cognitive impairment, it is clear that removing or ameliorating Aβ alone will not alleviate all cognitive impairment in aging [2]. This evidence concerns the gene APP and Alzheimer disease.